Status:
UNKNOWN
Portuguese Severe Asthma Registry: Getting Answers for Severe Asthma Patients
Lead Sponsor:
Sociedade Portuguesa de Pneumologia
Collaborating Sponsors:
GlaxoSmithKline
Conditions:
Severe Asthma
Eligibility:
All Genders
Brief Summary
Asthma currently affects 358 million individuals worldwide, posing a substantial burden on health care systems. In particular patients with severe asthma have higher morbidity, mortality and asthma-re...
Detailed Description
BACKGROUND Asthma currently affects 358 million individuals worldwide, posing a substantial burden on health care systems. Patients with severe asthma have higher morbidity, mortality and asthma-relat...
Eligibility Criteria
Inclusion
- be under treatment on step 4 or 5 according to GINA recommendations (GINA 2018);
- have verified the optimization of treatment adherence and comorbidities management;
- provide the signed consent to have his/her data included in the registry
Exclusion
- patients without given consent to participate will be excluded.
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04714567
Start Date
May 1 2021
End Date
December 1 2022
Last Update
November 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Hospitalar e Universitário de Coimbra
Coimbra, Portugal, 3000-075